Genetic Technologies Enters Multi-Billion-Dollar Consumer Genomics Market
August 16, 2021 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in Genomics based tests in health, wellness and...
Genetic Technologies Rapidly Accelerating Commercialization Plans
July 26, 2021 08:25 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 26, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics based tests in health, wellness and serious...
Genetic Technologies Strengthens Global Leadership in Genomics with Acquisition of EasyDNA
July 19, 2021 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 19, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in Genomics tests in health, wellness and serious...
Genetic Technologies Continues to Break New Ground as it Advances Development of its Predictive Risk Test for Multiple Cancers & Morbidities
July 09, 2021 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG, NASDAQ: GENE, "Company", "GTG"), a diversified Genomics and AI driven preventative health...
US Patent Office Grants Foundational Pharmacogenomic Patent
June 11, 2021 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, June 11, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business,...
Genetic Technologies’ COVID-19 Risk Test Now Available in US through Partnership with Infinity BiologiX
June 01, 2021 08:00 ET
|
Genetic Technologies Ltd
Key Highlights: Gene’s COVID-19 Risk Test released for sale in the US through IBXDesigned to predict disease severity to assist in informing decisions about disease risk, treatment options and...
Genetic Technologies Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®
May 13, 2021 09:01 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, May 13, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business,...
Genetic Technologies’ COVID-19 Risk Test Approved for Commercial Release
April 26, 2021 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, April 26, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business...
Genetic Technologies appoints Mike Tonroe as CFO
April 12, 2021 08:15 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, April 12, 2021 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), announces the appointment of Michael Tonroe...
Genetic Technologies Provides Update on COVID-19 Risk Test Launch
April 09, 2021 11:15 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, April 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a diversified Genomics and AI driven preventative health business...